# IOMERVU
> **NDA216017** · New Drug Application · Sponsor: BRACCO · Approved 2024-11-27
## Drug
- **FDA Application Number:** NDA216017
- **Application type:** New Drug Application
- **Brand name:** IOMERVU
- **Generic name:** Iomeprol
- **Active ingredients:** IOMEPROL
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** BRACCO
- **First approval:** 2024-11-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216017)
---
*AI Analytics · CC0 1.0*